NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
Big resistance at 2.53 for CTXR. Hopefully phase 3 talk soon will be the catalyst to cross that.

Could be a nice swing. Target 3$ a share.

This is not financial advice. Do your own DD. Your capital is at risk.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。